Optimal PEEP in Pediatric Patients Under 17 Years of Age.
NCT ID: NCT05726877
Last Updated: 2023-02-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
51 participants
INTERVENTIONAL
2022-10-17
2024-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Individualized Positive End-expiratory Pressure Evaluation Using the Intratidal Compliance-volume Profile in Children
NCT03533296
PEEP During Induction of Anesthesia in Small Children
NCT03540940
Fraction of Oxygen on Induction of Anesthesia in Infants
NCT04722276
Determination of Optimal Mask Ventilation Mode in Pediatrics Using Real-time Ultrasonography
NCT03881033
Optimal Inspiratory Pressure for Facemask Pressure-controlled Ventilation in Children
NCT02471521
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental arm
All patients will be enrolled in the same arm.
ventilation strategy
Titrating positive end-expiratory pressure
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ventilation strategy
Titrating positive end-expiratory pressure
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patients who are in age under 17 years
Exclusion Criteria
* had respiratory distress syndrome or bronchopulmonary dysplasia
* had laryngotracheal diseases
* had pulmonary hypertension
* receiving oxygen therapy
0 Years
16 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Seoul National University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hee-Soo Kim, MD.Ph.D.
Role: STUDY_CHAIR
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Seoul National University Hospital
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2208-091-1351
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.